5 incredible ASX growth stocks to buy for 2026

The Australian share market has no shortage of high-quality companies with the potential to grow earnings well above the market average over the long term.

While short-term volatility is always part of investing, history suggests that owning outstanding businesses with structural tailwinds, strong competitive positions, and scalable business models can be a powerful way to build wealth over time.

With 2026 shaping up to be another year where innovation, technology adoption, and global expansion matter, here are five ASX growth stocks that I think could be well worth a closer look for long-term investors.

Life360 Ltd (ASX: 360)

Life360 has established itself as a global leader in family safety and location-based services, with over 90 million monthly active users worldwide.

The company continues to execute on a highly scalable subscription model, converting free users into paying subscribers while expanding average revenue per user through new features and services. Importantly, Life360 has reached a point where strong revenue growth is now being matched by improving margins and cash flow.

Pro Medicus Ltd (ASX: PME)

Pro Medicus is widely regarded as one of the highest-quality businesses on the ASX.

Its Visage imaging platform is increasingly becoming the system of choice for large hospital networks in the United States, thanks to its speed, scalability, and cloud-based architecture. Long-term contracts, high switching costs, and expanding margins underpin a business model that is both resilient and highly profitable.

With strong earnings visibility, a growing pipeline of major contract wins, and a backdrop of radiologist shortages, I think Pro Medicus remains a standout ASX growth stock for investors.

REA Group Ltd (ASX: REA)

REA Group could be another ASX growth stock to buy. It is the property listings company best known for realestate.com.au, which remains the clear market leader in Australian property listings.

What makes REA a compelling growth stock is not just its dominant position, but its ability to monetise that leadership through premium products, data services, and advertising tools. The company also has exposure to offshore markets, such as India, providing additional growth optionality over time.

ResMed Inc. (ASX: RMD)

Another ASX growth stock that could be an incredible buy in 2026 is ResMed. It operates in the growing global sleep health and respiratory care market, supported by powerful demographic tailwinds.

Rising awareness of sleep apnoea, increasing diagnosis rates, and ongoing innovation in connected medical devices continue to drive long-term demand. The company's expanding software and data ecosystem also provides opportunities to deepen relationships with healthcare providers and patients.

WiseTech Global Ltd (ASX: WTC)

Finally, WiseTech Global could be a great option for growth investors in 2026. It operates at the heart of global supply chains through its CargoWise logistics software platform.

After a disappointing 2025 marked by leadership controversies and product launch delays, WiseTech Global's long-term growth story remains compelling. Global trade continues to become more complex, increasing demand for software that improves efficiency, compliance, and visibility across logistics networks.

And with its shares down heavily over the past 12 months, now could be a great time to make a patient long-term investment.

The post 5 incredible ASX growth stocks to buy for 2026 appeared first on The Motley Fool Australia.

Motley Fool contributor James Mickleboro has positions in Life360, Pro Medicus, REA Group, ResMed, and WiseTech Global. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Life360, ResMed, and WiseTech Global. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has positions in and has recommended Life360, ResMed, and WiseTech Global. The Motley Fool Australia has recommended Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The Motley Fool's purpose is to help the world invest, better. Click here now for your free subscription to Take Stock, The Motley Fool's free investing newsletter. Packed with stock ideas and investing advice, it is essential reading for anyone looking to build and grow their wealth in the years ahead. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson. 2026